Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FJ1I
|
||||
Former ID |
DNC010912
|
||||
Drug Name |
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530929] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H23Cl3N2O3
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [530929] | |
Cannabinoid receptor 1 | Target Info | Inhibitor | [530929] | ||
Cannabinoid receptor 2 | Target Info | Inhibitor | [530929] | ||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.